Alois B. Lang
Corporate Officer/Principal at University of Bern
Profile
Alois B.
Lang was the founder of Kenta Biotech AG, where he held the title of Chief Scientific Officer in 2006.
Currently, he is a Professor-Immunology at the University of Bern.
Previously, he worked as the Chief Development Officer at GeNeuro SA (Switzerland).
Dr. Lang obtained his doctorate degree from the Swiss Federal Institute of Technology.
Alois B. Lang active positions
| Companies | Position | Start |
|---|---|---|
| University of Bern | Corporate Officer/Principal | - |
Former positions of Alois B. Lang
| Companies | Position | End |
|---|---|---|
| GENEURO SA | Corporate Officer/Principal | 2018-12-30 |
Kenta Biotech AG
 Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Founder | - |
Training of Alois B. Lang
| Swiss Federal Institute of Technology | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Private companies | 1 |
|---|---|
Kenta Biotech AG
Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Alois B. Lang
